Literature DB >> 16533175

Osteoporosis: current trends in diagnosis and management.

Indira Kulenović1, Senija Rasić, Elvedin Kulenović.   

Abstract

Osteoporosis (OP) is a generalized skeletal disorder characterized by low bone mineral density (BMD), deterioration of the microarchitecture of bone tissue and susceptibility to fracture. Most frequently it occurs in postmenopausal women and the aged. It is a chronic condition of multifactorial etiology and is a major global healthcare problem in developed and rising in developing countries. Patients with uncomplicated OP are usually asymptomatic which contributes to serious under-diagnosing of this potentially devastating condition. It is estimated that less than half of patients with OP are diagnosed in many developed countries. Therefore preventive measures and timely diagnosis have to be a key aspect of management of this disorder. In this article we briefly underline pato-physiology of the disorder, review current methods of measuring bone mineral density, describe risk factors and evaluate current and potential therapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16533175      PMCID: PMC7192676          DOI: 10.17305/bjbms.2006.3205

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  17 in total

1.  A brief history of calcitonin.

Authors:  Eric Colman; Randy Hedin; Joslyn Swann; David Orloff
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

Review 2.  Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.

Authors:  B Lawrence Riggs; Lynn C Hartmann
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

3.  Teriparatide (forteo) for osteoporsis.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  2003-02-03       Impact factor: 1.909

Review 4.  Clinical practice. Postmenopausal osteoporosis.

Authors:  Clifford J Rosen
Journal:  N Engl J Med       Date:  2005-08-11       Impact factor: 91.245

Review 5.  Does this woman have osteoporosis?

Authors:  Amanda D Green; Cathleen S Colón-Emeric; Lori Bastian; Matthew T Drake; Kenneth W Lyles
Journal:  JAMA       Date:  2004-12-15       Impact factor: 56.272

6.  Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

Authors:  J Y Reginster; E Seeman; M C De Vernejoul; S Adami; J Compston; C Phenekos; J P Devogelaer; M Diaz Curiel; A Sawicki; S Goemaere; O H Sorensen; D Felsenberg; P J Meunier
Journal:  J Clin Endocrinol Metab       Date:  2005-02-22       Impact factor: 5.958

Review 7.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1994

Review 8.  Clinical use of bone densitometry: scientific review.

Authors:  Steven R Cummings; David Bates; Dennis M Black
Journal:  JAMA       Date:  2002-10-16       Impact factor: 56.272

9.  The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.

Authors:  Dennis M Black; Susan L Greenspan; Kristine E Ensrud; Lisa Palermo; Joan A McGowan; Thomas F Lang; Patrick Garnero; Mary L Bouxsein; John P Bilezikian; Clifford J Rosen
Journal:  N Engl J Med       Date:  2003-09-20       Impact factor: 91.245

10.  Ten years' experience with alendronate for osteoporosis in postmenopausal women.

Authors:  Henry G Bone; David Hosking; Jean-Pierre Devogelaer; Joseph R Tucci; Ronald D Emkey; Richard P Tonino; Jose Adolfo Rodriguez-Portales; Robert W Downs; Jayanti Gupta; Arthur C Santora; Uri A Liberman
Journal:  N Engl J Med       Date:  2004-03-18       Impact factor: 91.245

View more
  4 in total

1.  Validation of a food frequency questionnaire for women with osteoporosis.

Authors:  G A P Pereira; P S Genaro; L C Santos; K S Sarkis; M M Pinheiro; V L Szjenfeld; N J Schuch; L A Martini
Journal:  J Nutr Health Aging       Date:  2009-05       Impact factor: 4.075

2.  Evaluation of bone remodelling parameters after one year treatment with alendronate in postmenopausal women with osteoporosis.

Authors:  Elma Kučukalić-Selimović; Amina Valjevac; Almira Hadžović-Džuvo; Amra Skopljak-Beganović; Rubina Alimanovic-Alagić; Amera Brković
Journal:  Bosn J Basic Med Sci       Date:  2011-02       Impact factor: 3.363

Review 3.  The Multiple Effects of Vitamin D against Chronic Diseases: From Reduction of Lipid Peroxidation to Updated Evidence from Clinical Studies.

Authors:  Massimiliano Berretta; Vincenzo Quagliariello; Alessia Bignucolo; Sergio Facchini; Nicola Maurea; Raffaele Di Francia; Francesco Fiorica; Saman Sharifi; Silvia Bressan; Sara N Richter; Valentina Camozzi; Luca Rinaldi; Carla Scaroni; Monica Montopoli
Journal:  Antioxidants (Basel)       Date:  2022-05-30

4.  Effects of Ethyl Acetate Extract of Poncirus trifoliata Fruit for Glucocorticoid-Induced Osteoporosis.

Authors:  Hyung-Young Yoon; Yun-Seok Cho; Qinglong Jin; Hyun-Gyu Kim; Eun-Rhan Woo; Yoon-Sok Chung
Journal:  Biomol Ther (Seoul)       Date:  2012-01       Impact factor: 4.634

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.